TERM AND TERMINATION 13 Sample Clauses

TERM AND TERMINATION 13. This Agreement shall become effective as of 1st of May 2021 and shall remain in force during the performance of the Services, unless terminated in accordance with Section 13.2 below. 13.
View SourceView Similar (2)
TERM AND TERMINATION 13. Doba platnosti a ukončení 13.1 The term of this Agreement shall begin on the last date of signature by all parties, the Effective Date on the day of its publication in the Register of contracts and shall continue until the earlier of 1) the completion of the objectives of Study - XXX; 2) closure of enrollment period where the site has failed to recruit any patients; or 3) termination of the Agreement by Sponsor pursuant to this Section 13.2. 13.1 Doba platnosti této smlouvy začíná datem posledního podpisu všemi stranami, účinnosti dnem zveřejnění v registru smluv a pokračuje do té doby podle toho, co nastane dříve: 1) dokončení cílů studie – XXX; 2) ukončení období zařazování, kdy se pracoviště nepodařilo provést nábor jakýchkoli pacientů; nebo 3) ukončení smlouvy zadavatelem podle tohoto oddílu 13.2. 13.2 Sponsor and WORLDWIDE reserve the right to terminate this Agreement and/or Investigator's, Institution's, or any Study subject’s participation in the Study or the Study itself at any time for any reason, or no reason, effective on written notice from WORLDWIDE or Sponsor. Immediately upon receipt of a notice of termination, Institution and Investigator shall and shall cause Investigator to cease entering Study subjects into the Study, cease conducting procedures to the extent medically permissible on Study subjects already entered into the Protocol, and refrain from incurring additional costs and expenses to the extent possible. 13.2 Zadavatel a společnost WORLDWIDE si vyhrazují právo ukončit tuto smlouvu a/nebo účast zkoušejícího lékaře, zdravotnického zařízení nebo jakýchkoli subjektů hodnocení ve studii nebo samotnou studii, a to kdykoli z jakéhokoli důvodu nebo bez udání důvodu, s účinností na základě písemného oznámení od společnosti WORLDWIDE nebo zadavatele. Zdravotnické zařízení a zkoušející lékař ihned po obdržení oznámení o ukončení zastaví, a zajistí, aby zkoušející lékař zastavil zařazování subjektů hodnocení do studie, přestane provádět postupy v rozsahu, který je z lékařského hlediska přípustný, u subjektů hodnocení již zapsaných do protokolu, a zdrží se vytváření dalších nákladů a výdajů v maximálním možném rozsahu. 13.3 Upon termination or completion of the Study, Institution or Investigator shall (i) return, retain or dispose of all Study drugs and Clinical Supplies in accordance with the Protocol and instructions to be provided by WORLDWIDE and applicable Legal Requirements, (ii) arrange for all of Sponsor’s Confidential Information and...
View Source
TERM AND TERMINATION 13. 1 The term of this Agreement shall be for a period beginning with Date of Execution. Unless sooner terminated pursuant to Articles 13.2, 13.3, 14.1 or 17.5, the term of this Agreement shall end at such time as Lundbeck shall have no further obligation to make payments to Licensor on Net Sales of Licensed Products. Upon such termination, Lundbeck shall have a perpetual royalty-free license to such Licensor Know-How which is not or no longer covered by a Valid Claim.
View Source
TERM AND TERMINATION 13. Doba platnosti a ukončení 13.1 The term of this Agreement shall begin on the Effective Date and shall continue until the earlier of 1) the completion of the objectives of Study; 2) closure of enrollment period where the site has failed to recruit any patients; or 3) termination of the Agreement by Sponsor pursuant to this Section 13.2. 13.1 Doba platnosti této smlouvy začíná datem účinnosti a pokračuje do té doby podle toho, co nastane dříve: 1) dokončení cílů studie; 2) ukončení období zařazování, kdy se pracoviště nepodařilo provést nábor jakýchkoli pacientů; nebo 3) ukončení smlouvy zadavatelem podle tohoto oddílu 13.2. 13.2 Sponsor and WORLDWIDE reserve the right to terminate this Agreement and/or Investigator's, Institution's, or any Study subject’s participation in the Study or the Study itself at any time for any reason, or no reason, effective on written notice from WORLDWIDE or Sponsor. Immediately upon receipt of a notice of termination, Institution and Investigator shall and shall cause Investigator to cease entering Study subjects into the Study, cease conducting procedures to the extent medically permissible on Study subjects already entered into the Protocol, and refrain from incurring additional costs and expenses to the extent possible.
View Source
TERM AND TERMINATION 13. 1 Effectiveness This Agreement becomes effective on the date of signature of this Agreement and shall remain in full effect until the first anniversary after the End of Production unless mutually terminated by the Parties or terminated pursuant to Section 13.2 or Section 13.3 below. 13.2 Termination This Agreement may be early terminated with immediate effect: a) by a non-breaching Party if any other Party breaches any provision of this Agreement which will result in material adverse impact on the Project, and has failed to remedy such breach within sixty (60) days of receipt of a written notice from the non- breaching Party specifying such breach in question and requesting that such breach be remedied; b) by any Party (other than the bankrupt Party) if any other Party commences proceedings under applicable bankruptcy laws or dissolution, insolvency, liquidation or if any such proceeding is commenced against such other Party which remains undismissed for one hundred and eighty (180) days; c) by any Party in case of prolonged Force Majeure under the circumstances set out in Section 14, leading to the failure of realizing the purpose of the Agreement; 13.3 Cross-termination If any of the Definitive Agreements needs to be terminated due to a material breach or any insolvency or bankruptcy event of either Party or its Affiliates pursuant to the terms and conditions thereof, the non-breaching Party(ies) shall be entitled to escalate, among others, the 22 following matters according to the escalation principles set forth under Section 9 above, with the [***]KR PPGM as first instance, for a decision which shall be binding upon the Parties: a) any termination of or amendment to a Definitive Agreement or this Agreement; b) any possible measures or solutions for mitigating the negative consequences, whether in conjunction with or separate from such termination or amendment; and c) any compensation payable by a breaching Party to the non-breaching Party(ies). 13.4
View Source
TERM AND TERMINATION 13. 1 This Agreement shall commence on the Effective Date and shall continue for the Terms until its termination or expiry or the termination or expiry of all SOWs.
View Source
TERM AND TERMINATION 13. 1 The term of this Agreement shall begin on the Effective Date and shall continue until the earlier of 1) the completion of the objectives of Study; 2) closure of enrollment period where the site has failed to recruit any patients; or 3) termination of the Agreement by Sponsor pursuant to Section 13.2. 13.2 Sponsor and WCT reserve the right to terminate this Agreement and/or Investigator's, Institution's, or any Study subject's participation in the Study or the Study itself at any time for any reason, or no reason, effective on delivered written notice from WCT or Sponsor. Immediately upon receipt of a notice of termination, Institution and Investigator shall cease entering Study subjects into the Study, cease conducting procedures to the extent medically permissible on Study subjects already entered into the Protocol, and refrain from incurring additional costs and expenses to the extent possible.
View Source

Related to TERM AND TERMINATION 13

  • Term and Termination The term of this Agreement shall commence as of the Effective Date and shall stay in effect until the last to expire issued Valid Claim covering Licensed Products included in the Patent Rights, unless otherwise terminated earlier as provided below in this Article 4 (collectively, the “Term”). a. If LIMR believes in good faith that NewLink has materially breached its obligations under Section 9(a), then LIMR shall, in accordance with the terms of this paragraph 4, have the right and option to reduce NewLink’s exclusive License to a nonexclusive license or revoke the License in its entirety (by terminating the Agreement), provided that prior to taking this action: (1) LIMR shall provide NewLink written notice of the perceived breach, describing in detail the basis for LIMR’s belief that such perceived breach has occurred, describing the preferred method of cure and the proposed action to be taken by LIMR in the event of non-cure; and (2) NewLink shall have ninety (90) days to establish that it has met or will, within such ninety (90) day period, meet the applicable obligations; if the parties are still in dispute as to whether NewLink has met such obligations or cured such breach within ninety (90) days after receipt of notice from LIMR, the dispute will be submitted to binding arbitration in accordance with Section 23(b) of this Agreement, and if such arbitration determines that NewLink materially breached its obligations under Section 9(a) and did not cure such breach, then LIMR shall have the option to terminate this Agreement or to convert the License granted to NewLink in Section 2(a) to a non-exclusive license, in each case, upon prior written notice to NewLink. b. LIMR may terminate this Agreement immediately by providing NewLink written notice of termination, if: (1) NewLink ceases to function as a going concern; (2) a bankruptcy petition or action is filed or taken by or against NewLink under any United States bankruptcy law; (3) a receiver, assignee or other liquidating officer is appointed with control for all or substantially all of the assets of NewLink; or (4) NewLink makes an assignment for the benefit of creditors of all or substantially all its assets; provided, that, in the case of subclauses (b)(2), (3) or (4) above, such aforementioned circumstance is not remedied, dismissed or stayed within the earlier of sixty (60) days of (x) occurrence of (b)(2), (3) or (4) or (y) LIMR’s notice of its intent to terminate this Agreement; Notwithstanding anything in Sections 4(a) or (b) or 23 to the contrary, at any time that LIMR or NewLink believes that the other party has defaulted under this Agreement and that such default will irreparably harm such party, in addition to its rights under this Agreement and at law, such party shall have the right to seek all applicable equitable remedies. c. If NewLink fails to make any payment whatsoever due and payable to LIMR hereunder, LIMR shall have the right to terminate this Agreement effective on ninety (90) days written notice, unless NewLink shall make all such payments to LIMR within said ninety (90) day period, and provided that the payments demanded by LIMR are not disputed by NewLink. In the event of a dispute of such payments by NewLink, the parties shall use good faith efforts to resolve the dispute, which if not resolved by the end of four (4) months either party may submit the dispute to binding arbitration pursuant to Section 23(b). Any disputed payments submitted to arbitration hereunder be paid into escrow the arbitrator or other independent escrow agent acceptable to both parties in their reasonable discretion unless and until determined due by the arbitrator under Section 23(b), provided, however that if the arbitrator determines that amounts are payable by NewLink to LIMR, then such outstanding amounts will bear interest back to the date that they originally accrued at the default rate of Prime plus 4%. Prime shall be the prime rate published by the Wall Street Journal or if the Wall Street Journal publishes more than one prime rate, then the average of the prime rates published by the Wall Street Journal, and if the Wall Street Journal does not publish a prime rate, then the prime rate of the largest bank in Philadelphia, Pennsylvania. d. NewLink shall have the right to terminate this Agreement at any time on ninety (90) days prior written notice to LIMR, provided that NewLink shall remain obligated to complete payment of all amounts that have accrued and are owed to LIMR through the effective date of the termination. In the event NewLink terminates the Agreement, the license granted hereunder shall be deemed terminated, and all rights with respect to the subject matter thereof revert to LIMR and all further obligations of NewLink to LIMR (except for obligations accrued prior to such termination) shall automatically be terminated. e. Upon expiration or termination of this Agreement for any reason, nothing herein shall be construed to release either party from any obligation that has accrued prior to the effective date of such termination. NewLink and any Sublicensee thereof may, however, after the effective date of such termination, sell all then existing Licensed Products, and complete Licensed Products in the process of manufacture at the time of such termination and sell the same, provided that NewLink shall make the payments to LIMR as required by Articles 8 & 9 of this Agreement and shall submit the reports as required by Article 11 hereof. f. Sections 4(e), 4(f), 7(b) (but solely with respect to sales made pursuant to Section 4(e)), 11, 12, 13 (solely for the period specified therein), 14, 18, 19, 20, 21 and 23 shall survive termination or expiration of this Agreement.

  • Term and Termination of Agreement This Agreement shall terminate upon the earlier of termination of the Advisory Agreement or on expiration of the Expense Limit Period. The obligation of the Adviser under Section 1 of this Agreement and of the Trust under Section 2 of this Agreement shall survive the termination of the Agreement solely as to expenses and obligations incurred prior to the date of such termination.

  • Agreement Term and Termination This agreement will remain in effect until the expiration or termination of Customer’s Subscription, whichever is earliest. Customer may terminate this agreement at any time by contacting its Reseller. The expiration or termination of this agreement will only terminate Customer’s right to place new orders for additional Products under this agreement.

  • Term and Termination of the Agreement 9.1. The Agreement shall enter into force upon its signing by the Parties and shall remain in full force and effect until the Parties have fully and properly fulfilled their obligations (including, unequivocally in the case the term of any other agreement associated with the Agreement exceeds the term of the Agreement). 9.2. In the cases and under the conditions stipulated by the Agreement and/or Legislation, it is possible to terminate the Agreement before expiration of its term in whole or in part:

  • Contract Term and Termination 1. This Contract is concluded for a definite period of time, namely for the period of validity of the appointment of STC an issuer of unique identifiers. 2. During the period of validity of the appointment of STC an issuer of unique identifiers, the Contract may be terminated as follows: a) By a written agreement of the Contracting Parties according to the provision of Section 1981 of the Civil Code, while the Contract termination shall take effect at the moment determined in the agreement; the agreement shall also include an arrangement on settlement of mutual obligations and liabilities; b) By a written notice of withdrawal from the Contract under the terms and conditions determined in the provision of Section 2002 of the Civil Code in the event either Contracting Party breaches the Contract seriously; c) By a written notice of termination of the Ordering Party with a notice period of 3 months if the Issuer announces a change in the terms and conditions specified in the Operating Rules or STC API Specification, within the meaning of Article I (8) hereof; and the Ordering Party does not agree with such a change; d) By a written notice of termination of the Issuer with a notice period of 3 months if, during the negotiations of the Contracting Parties within the meaning of Article V (5) hereof or Article XII (6) hereof, the Contracting Parties reach no agreement concerning a change in the Price or in other terms and conditions hereof within 3 months following the start of such negotiations. 3. The Contracting Parties are entitled to withdraw from the Contract under the terms and conditions determined hereby. A withdrawal shall take effect on the date of delivery of the written notice of withdrawal to the other Contracting Party. All rights and obligations of the Contracting Parties under this Contract shall expire upon the withdrawal from this Contract except for those the nature of which clearly implies that they should continue. However, a withdrawal from the Contract shall not affect the entitlement to compensation for damage caused by a breach of the Contract and of the confidentiality obligation. The Contracting Parties shall keep the performance that they provided to each other before the effect date of the withdrawal from the Contract. 4. The Contracting Parties agree that the following shall be regarded as fundamental breach of Contract: a) Repeated delay of the Issuer of more than 15 days in the handover of UIs more than three times; b) Delay of the Ordering Party of more than 30 days with payment of two or more invoices; c) Bankruptcy is declared for the assets of the other Contracting Party or a proposal of bankruptcy is rejected for insufficient assets, or the other Contracting Party goes bankrupt, becomes insolvent, enters liquidation, negotiates with creditors concerning terms of a debt settlement, or an insolvency administrator, a trustee in bankruptcy, an administrator appointed in favour of creditors continues in the activity of the other Contracting Party, or a step or event occurs that would have (according to the applicable law) an effect similar to any of the steps or events above; In other cases and when in doubt, a breach of the Contract shall not be considered fundamental.